未登录

C

Christine Courteix

universite clermont auvergne

H指数:21

被引数:2,069

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

5-HT6 Receptor Inverse Agonists Modulate Diabetic Neuropathic Pain in Female Rats: Evidence for 5-HT6 Receptor Constitutive Activity

5-HT6受体反向激动剂调节雌性大鼠糖尿病神经病理性疼痛：5-HT6受体固有活性作用的证据

Journal of Neurochemistry

IF4

2025-08-040

PRE

Diabetic Neuropathic Pain and Serotonin: What Is New in the Last 15 Years?

IF3.9

2023-07-063

OAAI

The Safety of Medications used to Treat Peripheral Neuropathic Pain, Part 2 (Opioids, Cannabinoids and Other Drugs): review of Double-Blind, Placebo-Controlled, Randomized Clinical Trials

EXPERT OPINION ON DRUG SAFETY

IF3.1

2020-11-045

OAAI

mTOR activation by constitutively active serotonin6 receptors as new paradigm in neuropathic pain and its treatment

PROGRESS IN NEUROBIOLOGY

IF6.1

2020-10-0123

OAAI

The safety of medications used to treat peripheral neuropathic pain, part 1 (antidepressants and antiepileptics): review of double-blind, placebo-controlled, randomized clinical trials

EXPERT OPINION ON DRUG SAFETY

IF3.1

2020-05-2211

OAAI

L-Arginine supplementation prevents allodynia and hyperalgesia in painful diabetic neuropathic rats by normalizing plasma nitric oxide concentration and increasing plasma agmatine concentration

EUROPEAN JOURNAL OF NUTRITION

IF4.3

2017-07-1925

PREAI

Increasing spinal 5-HT2A receptor responsiveness mediates anti-allodynic effect and potentiates fluoxetine efficacy in neuropathic rats. Evidence for GABA release

PHARMACOLOGICAL RESEARCH

IF10.5

2017-04-0114

PREAI

Agomelatine: a new opportunity to reduce neuropathic pain-preclinical evidence

IF5.5

2016-01-1030

PREAI

Agomelatine induces antihyperalgesic effects in a rat model of neuropathic pain and produces an additive interaction with gabapentin

EUROPEAN NEUROPSYCHOPHARMACOLOGY

IF6.7

2013-10-010

PREAI

Structure-Based Design of PDZ Ligands as Inhibitors of 5-HT2A Receptor/PSD-95 PDZ1 Domain Interaction Possessing Anti-hyperalgesic Activity

ACS CHEMICAL BIOLOGY

IF3.8

2013-08-2316

PREAI

Evidence for a differential opioidergic involvement in the analgesic effect of antidepressants: prediction for efficacy in animal models of neuropathic pain?

BRITISH JOURNAL OF PHARMACOLOGY

IF7.7

2011-05-2634

OAAI

Oxaliplatin-induced cold hypersensitivity is due to remodelling of ion channel expression in nociceptors

EMBO MOLECULAR MEDICINE

IF8.3

2011-03-24313

OAAI

Disrupting 5-HT2A Receptor/PDZ Protein Interactions Reduces Hyperalgesia and Enhances SSRI Efficacy in Neuropathic Pain

MOLECULAR THERAPY

IF12

2010-08-0150

OAAI

Spinal effect of a neuropeptide FF analogue on hyperalgesia and morphine-induced analgesia in mononeuropathic and diabetic rats

BRITISH JOURNAL OF PHARMACOLOGY

IF7.7

2009-01-2930

OAAI

Agmatine induces antihyperalgesic effects in diabetic rats and a superadditive interaction with R(-)-3-(2-carboxypiperazine-4-yl)propyl-1-phosphonic acid, a N-methyl-D-aspartate-receptor antagonist

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

IF3.8

2007-09-0136

PREAI

Diabetes-induced mechanical hyperalgesia involves spinal mitogen-activated protein kinase activation in neurons and microglia via N-methyl-D-aspartate-dependent mechanisms

MOLECULAR PHARMACOLOGY

IF3

2006-10-01206

PREAI

Evidence for an exclusive antinociceptive effect of nociceptin/orphanin FQ, an endogenous ligand for the ORL1 receptor, in two animal models of neuropathic pain

IF5.5

2004-07-0185

PRE

Spinal effect of the cholecystokinin-B receptor antagonist CI-988 on hyperalgesia, allodynia and morphine-induced analgesia in diabetic and mononeuropathic rats

IF5.5

2000-10-0134

PRE

Evidence for an involvement of tachykinins in allodynia in streptozocin-induced diabetic rats

EUROPEAN JOURNAL OF PHARMACOLOGY

IF4.7

2000-07-0117

PREAI

Effect of tachykinin receptor antagonists in experimental neuropathic pain

EUROPEAN JOURNAL OF PHARMACOLOGY

IF4.7

1998-11-0146

PREAI